My research focuses on the discovery and characterisation of monoclonal antibodies (mAbs) targeting blood stage malaria vaccine candidates. I then use these mAbs to design new, more potent vaccine candidates.
I completed my undergraduate degree in Biochemistry, followed by a MRes in Molecular Microbiology at the University of Bath. After my studies, I worked in research and development for a leading gene and cell therapy company in Oxfordshire. I then completed my PhD at The Jenner Institute, funded by the Oxford-MRC Doctoral Training Partnership, where I researched novel blood-stage malaria vaccines based around the RH5 interacting protein (PfRIPR). I am also an Associate Fellow of the Higher Education Academy and teach on various bioscience courses.